Veradermics, Inc.
VDPHL01
Androgenetic Alopecia
Countdown
56days
Phase 2 readout · ~ Aug 31, 2026 estimated
What's at stake
Phase 2 trial results for VDPHL01 in Androgenetic Alopecia are due ~ Aug 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 13h ago
“CT.gov NCT06527365: Phase 2 trial, sponsor Veradermics, Inc., drug VDPHL01. Primary completion date 2026-08 (estimated).”